IRIS Accounts Production v23.3.1.45 13596373 Board of Directors Board of Directors 1.11.22 31.10.23 31.10.23 false true false false true false Ordinary 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh135963732022-10-31135963732023-10-31135963732022-11-012023-10-31135963732021-08-31135963732021-09-012022-10-31135963732022-10-3113596373ns10:Originalns15:EnglandWales2022-11-012023-10-3113596373ns14:PoundSterlingns10:Original2022-11-012023-10-3113596373ns10:Originalns10:Director12022-11-012023-10-3113596373ns10:Original2022-11-012023-10-3113596373ns10:Originalns10:Director22022-11-012023-10-3113596373ns10:Original2023-10-3113596373ns10:Originalns10:PrivateLimitedCompanyLtd2022-11-012023-10-3113596373ns10:Originalns10:SmallEntities2022-11-012023-10-3113596373ns10:Originalns10:AuditExempt-NoAccountantsReport2022-11-012023-10-3113596373ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-11-012023-10-3113596373ns10:SmallCompaniesRegimeForAccountsns10:Original2022-11-012023-10-3113596373ns10:Originalns10:FullAccounts2022-11-012023-10-3113596373ns10:Originalns10:OrdinaryShareClass12022-11-012023-10-3113596373ns10:Originalns10:RegisteredOffice2022-11-012023-10-3113596373ns10:Original2022-10-3113596373ns10:Originalns5:CurrentFinancialInstruments2023-10-3113596373ns10:Originalns5:CurrentFinancialInstruments2022-10-3113596373ns5:ShareCapitalns10:Original2023-10-3113596373ns5:ShareCapitalns10:Original2022-10-3113596373ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-10-3113596373ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-10-3113596373ns10:Originalns5:FurnitureFittings2022-11-012023-10-3113596373ns10:Originalns5:ComputerEquipment2022-11-012023-10-3113596373ns10:Original2021-09-012022-10-3113596373ns10:Originalns5:FurnitureFittings2022-10-3113596373ns10:Originalns5:ComputerEquipment2022-10-3113596373ns10:Original2022-10-3113596373ns10:Originalns5:FurnitureFittings2023-10-3113596373ns10:Originalns5:ComputerEquipment2023-10-3113596373ns10:Originalns5:FurnitureFittings2022-10-3113596373ns10:Originalns5:ComputerEquipment2022-10-3113596373ns10:Originalns5:AdditionsToInvestments2023-10-3113596373ns10:Originalns5:RevaluationsIncreaseDecreaseInInvestments2023-10-3113596373ns10:Originalns5:CostValuation2023-10-3113596373ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-10-3113596373ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-10-3113596373ns10:Originalns10:OrdinaryShareClass12023-10-31
REGISTERED NUMBER: 13596373 (England and Wales)













Unaudited Financial Statements

for the Year Ended 31 October 2023

for

Shape Health Consulting Ltd

Shape Health Consulting Ltd (Registered number: 13596373)






Contents of the Financial Statements
for the Year Ended 31 October 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Shape Health Consulting Ltd

Company Information
for the Year Ended 31 October 2023







DIRECTORS: Dr M J Divall
Mrs J N Divall





REGISTERED OFFICE: 10 Draycote
Rugby
CV23 9RB





REGISTERED NUMBER: 13596373 (England and Wales)





ACCOUNTANTS: Anderson Barrowcliff LLP
Chartered Accountants
3 Kingfisher Court
Bowesfield Park
Stockton on Tees
TS18 3EX

Shape Health Consulting Ltd (Registered number: 13596373)

Balance Sheet
31 October 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 3,371 2,142
Investments 5 200,730 -
204,101 2,142

CURRENT ASSETS
Debtors 6 77,535 145,133
Cash at bank 123,379 266,341
200,914 411,474
CREDITORS
Amounts falling due within one year 7 126,484 182,314
NET CURRENT ASSETS 74,430 229,160
TOTAL ASSETS LESS CURRENT
LIABILITIES

278,531

231,302

PROVISIONS FOR LIABILITIES 843 -
NET ASSETS 277,688 231,302

CAPITAL AND RESERVES
Called up share capital 8 1 1
Retained earnings 277,687 231,301
SHAREHOLDERS' FUNDS 277,688 231,302

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Shape Health Consulting Ltd (Registered number: 13596373)

Balance Sheet - continued
31 October 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 22 February 2024 and were signed on its behalf by:




Mrs J N Divall - Director



Dr M J Divall - Director


Shape Health Consulting Ltd (Registered number: 13596373)

Notes to the Financial Statements
for the Year Ended 31 October 2023

1. STATUTORY INFORMATION

Shape Health Consulting Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on cost
Computer equipment - 33% on cost and 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Investments
Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

Shape Health Consulting Ltd (Registered number: 13596373)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2023

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 November 2022 1,381 973 2,354
Additions - 2,790 2,790
At 31 October 2023 1,381 3,763 5,144
DEPRECIATION
At 1 November 2022 57 155 212
Charge for year 346 1,215 1,561
At 31 October 2023 403 1,370 1,773
NET BOOK VALUE
At 31 October 2023 978 2,393 3,371
At 31 October 2022 1,324 818 2,142

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST OR VALUATION
Additions 209,704
Revaluations (8,974 )
At 31 October 2023 200,730
NET BOOK VALUE
At 31 October 2023 200,730

Cost or valuation at 31 October 2023 is represented by:

Other
investments
£   
Valuation in 2023 (8,974 )
Cost 209,704
200,730

The fixed asset investment represents shares held. At the year end the shares were valued at the prevailing stock market price. As a result £8,974 has been debited to the Profit and Loss as a fair value adjustment.

Shape Health Consulting Ltd (Registered number: 13596373)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2023

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 47,956 143,081
Other debtors 29,579 2,052
77,535 145,133

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Taxation and social security 57,071 85,359
Other creditors 69,413 96,955
126,484 182,314

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
100 Ordinary £0.01 1 1